July 2024

antipsychotic

Endocannabinoid Degradation Enzyme Inhibitors as Potential Antipsychotics: A Medicinal Chemistry Perspective

This comprehensive study, available on PubMed Central, examines the potential of targeting endocannabinoid degradation enzyme inhibitors for the development of new antipsychotic medications. Schizophrenia and other psychotic disorders often lack effective treatments with minimal side effects, driving the need for innovative approaches. The endocannabinoid system, known for its role in Read more…

By Yana Djonua, ago
cancer

Short-Term Medical Cannabis Benefits for Palliative Cancer Patients

Recent research published under the title “Short-Term Medical Cannabis Treatment Regimens Produced Beneficial Effects among Palliative Cancer Patients” has revealed promising results regarding the use of medical cannabis among those undergoing palliative care for cancer. The study, accessible through the National Center for Biotechnology Information (NCBI), indicates significant improvements in Read more…

By Yana Djonua, ago